C4 Therapeutics, Inc. (CCCC) ownership: Top institutional holder: MORGAN STANLEY ($23.86M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| MORGAN STANLEY | 9072400.00 | $23.86M | 2026-03-31 |
| RA CAPITAL MANAGEMENT, L.P. | 8000000.00 | $21.04M | 2026-03-31 |
| Bain Capital Life Sciences Investors, LLC | 7171910.00 | $18.86M | 2026-03-31 |
| Lynx1 Capital Management LP | 6998902.00 | $18.41M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3861852.00 | $10.16M | 2026-03-31 |
| Soleus Capital Management, L.P. | 3803942.00 | $10.00M | 2026-03-31 |
| VANGUARD GROUP INC | 4379815.00 | $8.37M | 2025-12-31 |
| TWO SIGMA INVESTMENTS, LP | 3035634.00 | $7.98M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-04-01 | |
| Sell | null | 2026-04-01 | |
| Sell | null | 2026-02-13 | |
| Sell | null | 2026-02-13 | |
| Sell | null | 2026-02-13 | |
| Sell | null | 2026-02-13 |
Back to CCCC overview · CCCC earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.